Conversely, shutting down sarcosine production in
cancer cells blocked invasion.
Targeting stromal cells as well as
the cancer cells blocks multiple cell signalling pathways that are used by cancer cells to become aggressive.
«Inflammatory breast cancer is a rare and very aggressive disease in which
cancer cells block lymph vessels in the skin of the breast.
Rather,
cancer cells block lymph vessels in the skin of the breast, causing it to look red and feel warm.
Not exact matches
It's only been tested on mice so far, but the results are tremendously promising for an antibody Stanford researchers have been experimenting with that
blocks the body from «eating»
cancer cells.
Recent findings from the University of Texas MD Anderson
Cancer Center suggests that capsaicin, the active chemical compound that gives chile peppers their heat, may reduce and even block chronic inflammation pathways in cancer
Cancer Center suggests that capsaicin, the active chemical compound that gives chile peppers their heat, may reduce and even
block chronic inflammation pathways in
cancer cancer cells.
Cancer: Flaxseed may protect against breast cancer, prostate cancer, and colon cancer by inhibiting tumor growth and blocking enzymes that are involved in the spread of tumor
Cancer: Flaxseed may protect against breast
cancer, prostate cancer, and colon cancer by inhibiting tumor growth and blocking enzymes that are involved in the spread of tumor
cancer, prostate
cancer, and colon cancer by inhibiting tumor growth and blocking enzymes that are involved in the spread of tumor
cancer, and colon
cancer by inhibiting tumor growth and blocking enzymes that are involved in the spread of tumor
cancer by inhibiting tumor growth and
blocking enzymes that are involved in the spread of tumor
cells.
Inflammatory breast
cancer is a rare and aggressive form of breast
cancer that occurs when malignant
cells block the skin and lymph vessels of the...
Chronic cigarette smoke exposure, as noted in many human
cancers, tends to
block these
cell maturation genes from properly turning on, says Baylin.
The antibody
blocks PD - 1 proteins, freeing T
cells to attack the
cancer.
To test whether those
cancer genes help the
cell survive, they tried
blocking them.
While the combination therapies
block off the principal pathway that
cancer cells use to fuel their growth, the
cells come to bypass this blockade and, like vehicles on a detour route, make use of additional pathways to continue growing and spreading.
They also determined that
blocking the enzyme reduces multiple myeloma regeneration in experimental models derived from patient
cancer cells.
The researchers confirmed this hypothesis by showing that if they
blocked YAP1 they could inhibit stem
cells from undergoing self - renewal, forming blood vessel - like structures, and reduce lung
cancer cell growth in mice.
Nicotine from cigarettes is a highly addictive drug that can stimulate
cell growth and
block cell death — two hallmark characteristics of
cancer.
Once we know all
cancer's major evolutionary escape routes — and it turns there may be just a few — it may be possible to
block them all off with T -
cells or drugs like them.
An experimental drug in early development for aggressive brain tumors can cross the blood - brain tumor barrier, kill tumor
cells and
block the growth of tumor blood vessels, according to a study led by researchers at the Ohio State University Comprehensive
Cancer Center — Arthur G. James
Cancer Hospital and Richard J. Solove Research Institute (OSUCCC — James).
Schwarz and her colleagues used three different drugs, alone and in combination, to deprive cervical tumors of glucose and
block downstream metabolic pathways that help protect
cancer cells from building up toxic free radicals.
«
Cancer cells» communication path
blocked.»
Women with high levels of FGF1 were less likely to respond to platinum - based drugs, but
blocking the gene makes their
cells lose their resistance (British Journal of
Cancer, DOI: 10.1038 / bjc.2012.410).
With that knowledge, they screened more than four dozen monoclonal antibodies — unique agents that can stop
cells from growing or forming tumors and can be mass produced — before finding two that
block tumor creation in both types of
cancer.
There is currently a PD - 1 antibody on the market that
blocks T
cell exhaustion in patients with solid tumors, like lung
cancer and melanoma.
The discovery has powerful implications for
cancer immunotherapy researchers say: by
blocking the mechanism with a drug, it may be possible to turn the attack - suppressing
cells into tumor - attacking
cells.
In the study, they found that miR - 182 suppressed Bcl2L12, a
cancer gene that
blocks cancer cell death in response to chemo - and radiation therapy.
However, along with this seemingly linear storyline in which retinoids
block progesterone's promotion of CK5 +
cells, previous work in the lab of CU
Cancer Center investigator Peter Kabos, MD, and others shows that breast
cancers treated with anti-estrogen drugs like tamoxifen or aromatase inhibitors show an increased population of CK5 +
cells — it is as if these therapies remove the roadblock of estrogen - dependent
cells, leaving CK5 +
cells to proliferate.
Checkpoint inhibitors
block that handshake, which alerts immune
cells to
cancer cells and target them for destruction.
A phase 3 trial of lenalidomide / dexamethasone plus ixazomib (Ninlaro ®), a «proteasome inhibitor» that
blocks the ability of
cancer cells to reuse certain proteins.
«The knowledge we have gained may be applicable for future intervention of this process to
block the replication of viral pathogens and
cancer cells.»
«For this reason, we decided to combine vitamin C with a PARP inhibitor, a drug type known to cause
cancer cell death by
blocking the repair of DNA damage, and already approved for treating certain patients with ovarian
cancer.»
The researchers observed the effect of the synthetically produced molecule, JK - 31, on the growth and proliferation of a model human breast
cancer cell line and found that it effectively
blocked the protein cyclin - dependent kinase 1 (CDK1), which plays a key part in the process of the division of
cancer cells, and therefore inhibited the proliferation of the
cells.
DMNT inhibitors, such as 5 - azacytidine and decitabine, boost the interactions of PARP inhibitors to
block these proteins even further, causing
cancer cell death, the researchers found.
They were able to
block proliferation of several
cancer stem
cell lines.
PARP inhibitors target and
block proteins which
cancer cells depend on to repair DNA for their survival.
But their overriding interest in BPTES, says Slusher, was in how it works: by
blocking the production of glutamine, an amino acid that acts as a building
block of
cells and is used frequently by pancreatic
cancers to create more
cancer cells.
The researchers demonstrated that
blocking the PGD enzyme genetically or with a pharmacologic inhibitor reversed the epigenetic reprogramming and malignant gene expression changes detected in distant metastases, and also strongly inhibited their tumor - forming capacity, with no effect on normal
cells or peritoneal pancreatic
cancer controls.
The scientists identified several, including the investigational
cancer drug BEZ235, which
blocked a key metabolic pathway in flu - infected human lung epithelial
cells.
Moreover, epalrestat, a drug that inhibits AKR1B1 and is approved in Japan to treat peripheral neuropathies associated with diabetes, was similarly able to
block the growth and metastasis of human basal - like breast
cancer cells.
«In order to
block tumor recurrence after radiation therapy, we used an antibody to target and inhibit these
cancer stem
cells,» said Dr. Xu.
The studies not only point to the future possibility of specific microRNAs as a treatment for colorectal
cancer, but also to the importance of external metabolic events conducted outside the
cancer cell in the progression of the disease — factors that could someday be targeted to help slow metastasis, or even
block it entirely.
The finding, reported by a Stand Up to
Cancer - Prostate Cancer Foundation Dream Team in the May 21 edition of the journal Cell, is based on an analysis of tumor samples from 150 men with metastatic prostate cancer that no longer responded to standard hormone - blocking th
Cancer - Prostate
Cancer Foundation Dream Team in the May 21 edition of the journal Cell, is based on an analysis of tumor samples from 150 men with metastatic prostate cancer that no longer responded to standard hormone - blocking th
Cancer Foundation Dream Team in the May 21 edition of the journal
Cell, is based on an analysis of tumor samples from 150 men with metastatic prostate
cancer that no longer responded to standard hormone - blocking th
cancer that no longer responded to standard hormone -
blocking therapy.
Liang Xu, Ph.D. member of the KU
Cancer Center's Drug Discovery, Delivery and Experimental Therapeutics program and associate professor of molecular biosciences at KU, has discovered that targeting a
cell - surface receptor called «CD44s» can
block pancreatic tumor formation and recurrence after radiotherapy.
«
Blocking the damage response in normal
cells that have been bathed in chemotherapy could be instrumental in keeping errant or dormant
cancer cells from starting down the path to proliferation,» he said.
«We have shown that when FBW7 is functionally inactivated this leads to a
block of degradation of the stem
cell protein SOX9 which becomes more stable in the brain cancer cells,» said first author Aldwin Suryo Rahmanto at the department of Cell and Molecular Biol
cell protein SOX9 which becomes more stable in the brain
cancer cells,» said first author Aldwin Suryo Rahmanto at the department of
Cell and Molecular Biol
Cell and Molecular Biology.
Autophagy is a process by which
cancer cells recycle essential building
blocks to fuel further growth.
«It is currently impractical to directly restore Apc function in patients with colorectal
cancer, and past evidence suggests that completely
blocking Wnt signaling would likely be severely toxic to normal intestinal
cells,» Lowe says.
In addition to the COX enzyme pathway, Dr. Roberts says other studies have shown that aspirin
blocks additional
cell - signaling cascades that promote
cancer development.
What's more, the researchers found that
blocking this mechanism with HCQ — a drug used to treat malaria that has been shown in previous studies to
block autophagy — limited BRAF inhibitor - induced autophagy and enhanced
cancer cell death in mouse models.
The
cancer cell thinks it's getting cholesterol to provide the nutritional building
blocks needed to grow and proliferate.
This blood vessel normalization results in an increased barrier function on the one hand — thereby
blocking cancer cell dissemination and metastasis - and in enhanced tumor perfusion on the other hand, which increases the response of the tumor to chemotherapy.
But scientists at the Lewis Katz School of Medicine at Temple University (LKSOM) now think they can help overcome that problem, thanks to their discovery of a small molecule that selectively kills BRCA - deficient
cancer cells by
blocking the activity of an alternative DNA repair pathway.